Destiny Pharma plc
An innovative pharmaceutical company dedicated to the development of novel antimicrobial products.
Launch date
Employees
Market cap
€4.6m
Enterprise valuation
(€3m) (Public information from Aug 2024)
Share price
£0.02994 DEST.L
Company register number 03167025
Lewes England (HQ)
Financials
Estimates*
GBP | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Revenues | - | - | - | - | - | - | 1.5m |
EBITDA | (6.1m) | (5.6m) | (6.5m) | (6.3m) | (7.8m) | (6.7m) | - |
Profit | - | (4.7m) | (5.4m) | (5.3m) | (6.5m) | (5.7m) | - |
EV / EBITDA | -1.1x | -1.1x | -0.5x | -1.4x | -0.4x | -0.7x | - |
R&D budget | - | 2.9m | - | - | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
£4.8m | Early VC | ||
£2.8m | Early VC | ||
N/A | €16.7m Valuation: €71.3m -41.0x EV/LTM EBITDA | IPO | |
* | N/A | £1.6m | Grant |
N/A | £11.5m | Post IPO Equity | |
* | N/A | Grant | |
* | N/A | £7.3m | Post IPO Equity |
Total Funding | €11.0m |
Recent News about Destiny Pharma plc
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.